• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

COPD

COPD chronic obstructive pulmonary disease lungs
Pharma

GSK revs up launch plans after Nucala's FDA approval in COPD

The thumbs-up makes Nucala the second biologic approved in COPD and the third new therapy cleared for the disease by the FDA in less than a year.
Fraiser Kansteiner May 22, 2025 3:10pm
Asthma inhaler

AZ looks to grow Airsupra's reach with new asthma data

May 19, 2025 12:15pm
Hand holding blue asthma inhaler with spray coming out

AZ's Breztri set up for label expansion with 2 asthma trial wins

May 2, 2025 11:30am
Sanofi

Sanofi off to a promising start in launch of Dupixent for COPD

Apr 24, 2025 10:52am
pharmacoeconomics Leerink

Leerink uses broad model to weigh drugs' cost-effectiveness

Feb 18, 2025 8:56am
COPD

Verona's new COPD drug Ohtuvayre racked up sales of $42M in 2024

Jan 7, 2025 1:27pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings